Daehan New Pharm Co., Ltd. (KOSDAQ: 054670)

Daehan New Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Sep 30, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Cash & Equivalents	716.08	411.96	198.09	221.61	940.54	162.12
Short-Term Investments	1,003	984.31	1,172	9	-	6.03
Cash & Short-Term Investments	1,719	1,396	1,370	230.61	940.54	168.15
Cash Growth	0.36%	1.90%	494.20%	-75.48%	459.34%	-75.23%
Accounts Receivable	46,088	45,992	46,411	38,742	33,626	27,225
Other Receivables	-	-	-	1,745	1,147	859.91
Receivables	46,088	45,992	46,411	41,785	36,145	28,085
Inventory	7,245	6,453	5,568	6,421	6,658	9,147
Prepaid Expenses	-	-	-	694	15.55	8.42
Other Current Assets	1,903	1,401	2,237	2,605	1,679	887.64
Total Current Assets	56,954	55,242	55,586	52,498	46,034	38,959
Property, Plant & Equipment	16,406	15,318	14,650	13,845	12,674	11,256
Long-Term Investments	46,238	46,325	45,835	46,212	26,638	26,696
Other Intangible Assets	2,938	3,576	3,931	282.66	335.02	354.22
Long-Term Accounts Receivable	6,542	5,989	6,417	0.04	0.04	70.44
Long-Term Deferred Tax Assets	326.77	338.98	203.83	-	-	-
Other Long-Term Assets	-	-	-	602.64	715.86	694.3
Total Assets	129,405	126,789	126,623	118,852	111,827	119,113
Accounts Payable	6,591	5,627	6,808	3,457	3,099	3,103
Accrued Expenses	-	-	-	880.09	1,050	665.38
Short-Term Debt	39,830	37,221	30,307	26,990	17,902	28,840
Current Portion of Long-Term Debt	2,064	2,376	5,620	2,750	-	-
Current Income Taxes Payable	256.42	169.74	572.8	150.6	876.63	-
Other Current Liabilities	690.12	615.34	378.36	2,663	1,559	2,194
Total Current Liabilities	49,432	46,009	43,686	36,892	24,486	34,802
Long-Term Debt	1,668	8,277	3,692	5,350	6,778	2,250
Long-Term Deferred Tax Liabilities	-	-	-	667.58	1,714	2,588
Other Long-Term Liabilities	1,734	2,407	3,583	1,500	1,356	1,285
Total Liabilities	55,384	58,658	52,825	45,306	35,509	42,049
Common Stock	7,177	6,714	6,714	6,714	6,714	6,445
Additional Paid-In Capital	55,389	50,638	50,583	50,583	50,583	48,884
Retained Earnings	10,140	9,466	15,186	13,399	16,170	15,809
Treasury Stock	-3,075	-3,075	-3,075	-3,075	-3,075	-
Comprensive Income & Other	4,389	4,389	4,389	5,926	5,926	5,926
Shareholders' Equity	74,021	68,132	73,798	73,547	76,318	77,064
Total Liabilities & Equity	129,405	126,789	126,623	118,852	111,827	119,113
Total Debt	43,562	47,874	39,620	35,090	24,680	31,090
Net Cash (Debt)	-41,843	-46,478	-38,249	-34,859	-23,739	-30,922
Net Cash Per Share	-2987.50	-3547.49	-2912.31	-2591.49	-1763.58	-2381.47
Filing Date Shares Outstanding	12.31	13.21	12.5	13.11	13.11	12.89
Total Common Shares Outstanding	12.31	13.21	12.5	13.11	13.11	12.89
Working Capital	7,522	9,233	11,900	15,606	21,547	4,157
Book Value Per Share	6012.99	5156.83	5901.96	5610.60	5821.99	5978.46
Tangible Book Value	71,083	64,555	69,866	73,264	75,983	76,710
Tangible Book Value Per Share	5774.33	4886.15	5587.56	5589.04	5796.43	5950.98
Land	-	-	-	8,291	8,291	8,291
Buildings	-	-	-	5,676	4,514	3,286
Machinery	-	-	-	6,500	5,791	7,736
Construction In Progress	-	-	-	86.84	356.6	103.8

Source: S&P Capital IQ. Standard template. Financial Sources.